Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Calabresi

Showing results (91-100 of 169) with videos related to

Pageof 17
Sort By:
Oncotarget|December 13, 2017
Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in <i>JAK2V617F</i> mutated cells through PP2A/CIP2A axisNiccolò Bartalucci, Laura Calabresi, Manjola Balliu, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|December 15, 2022
Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasisAlice Ossoli, Ilenia Minicocci, Marta Turri, et al.
Atherosclerosis|August 21, 2015
Cholesterol trafficking-related serum lipoprotein functions in children with cholesteryl ester storage diseaseFrancesca Zimetti, Elda Favari, Paola Cagliero, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 27, 2020
Activation of Naturally Occurring Lecithin:Cholesterol Acyltransferase Mutants by a Novel Activator CompoundChiara Pavanello, Alice Ossoli, Marta Turri, et al.
Journal of Clinical Lipidology|June 5, 2012
Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemiaPaola Conca, Silvana Pileggi, Sara Simonelli, et al.
Cell Metabolism|August 3, 2010
Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosisGiuseppe Lo Sasso, Stefania Murzilli, Lorena Salvatore, et al.
Journal of Clinical Medicine|July 26, 2020
Low Plasma Lecithin: Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney DiseaseAndrea Baragetti, Alice Ossoli, Arianna Strazzella, et al.
Atherosclerosis Plus|January 16, 2023
Two novel variants in the lecithin:cholesterol acyltransferase gene resulted in classic LCAT deficiencyMargareta Fistrek Prlic, Marijana Coric, Laura Calabresi, et al.
Atherosclerosis|August 24, 2005
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genesLivia Pisciotta, Laura Calabresi, Graziana Lupattelli, et al.
Journal of Clinical Lipidology|February 18, 2014
Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid PlusMassimiliano Ruscica, Monica Gomaraschi, Giuliana Mombelli, et al.
Pageof 17

Showing results (91-100 of 169) with videos related to

Sort By:
Pageof 17
Oncotarget|December 13, 2017
Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in <i>JAK2V617F</i> mutated cells through PP2A/CIP2A axisNiccolò Bartalucci, Laura Calabresi, Manjola Balliu, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|December 15, 2022
Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasisAlice Ossoli, Ilenia Minicocci, Marta Turri, et al.
Atherosclerosis|August 21, 2015
Cholesterol trafficking-related serum lipoprotein functions in children with cholesteryl ester storage diseaseFrancesca Zimetti, Elda Favari, Paola Cagliero, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 27, 2020
Activation of Naturally Occurring Lecithin:Cholesterol Acyltransferase Mutants by a Novel Activator CompoundChiara Pavanello, Alice Ossoli, Marta Turri, et al.
Journal of Clinical Lipidology|June 5, 2012
Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemiaPaola Conca, Silvana Pileggi, Sara Simonelli, et al.
Cell Metabolism|August 3, 2010
Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosisGiuseppe Lo Sasso, Stefania Murzilli, Lorena Salvatore, et al.
Journal of Clinical Medicine|July 26, 2020
Low Plasma Lecithin: Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney DiseaseAndrea Baragetti, Alice Ossoli, Arianna Strazzella, et al.
Atherosclerosis Plus|January 16, 2023
Two novel variants in the lecithin:cholesterol acyltransferase gene resulted in classic LCAT deficiencyMargareta Fistrek Prlic, Marijana Coric, Laura Calabresi, et al.
Atherosclerosis|August 24, 2005
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genesLivia Pisciotta, Laura Calabresi, Graziana Lupattelli, et al.
Journal of Clinical Lipidology|February 18, 2014
Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid PlusMassimiliano Ruscica, Monica Gomaraschi, Giuliana Mombelli, et al.
Pageof 17